SL Science Holding Ltd(SLBT)
$0.64-0.08 (-11.68%)
SLBT
SL Science Holding Ltd financials statements
$0.64
At close:-0.08 (-11.68%)
Want to see SLBT full AI Analyst Report?
SL Science Holding Ltd (SLBT) Ratios
11 Followers
SL Science Holding Ltd Ratios
SLBT's free cash flow for Q2 2025 was $-225.00. For the 2025 fiscal year, SLBT's free cash flow was decreased by $-158.00 and operating cash flow was $-67.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 3.05 | 84.61 | 19.09 |
| Quick Ratio | 3.05 | 64.96 | 11.01 |
| Cash Ratio | 2.69 | 53.18 | 1.51 |
| Solvency Ratio | -6.99 | -5.58 | 0.65 |
| Operating Cash Flow Ratio | -4.08 | 4.05 | -13.41 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 893.55K | $ 5.65M | $ 2.83M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.08 | 0.00 | 0.13 |
| Debt-to-Equity Ratio | 0.09 | 0.00 | 0.15 |
| Debt-to-Capital Ratio | 0.09 | 0.00 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.23 | 1.04 | 1.19 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.28 | 3.20 | 2.04 |
| Profitability Margins | |||
| Gross Profit Margin | 35.27% | 57.46% | 83.96% |
| EBIT Margin | -174.65% | -35.56% | 11.02% |
| EBITDA Margin | -170.39% | -34.16% | 15.25% |
| Operating Profit Margin | -174.65% | -35.56% | 11.02% |
| Pretax Profit Margin | -173.85% | -33.70% | 60.62% |
| Net Profit Margin | -173.85% | -35.42% | 45.40% |
| Continuous Operations Profit Margin | -173.85% | -35.42% | 45.40% |
| Net Income Per EBT | 100.00% | 105.08% | 74.88% |
| EBT Per EBIT | 99.54% | 94.78% | 550.33% |
| Return on Assets (ROA) | -135.59% | -20.08% | 9.41% |
| Return on Equity (ROE) | -167.25% | -20.80% | 11.17% |
| Return on Capital Employed (ROCE) | -163.39% | -20.40% | 2.39% |
| Return on Invested Capital (ROIC) | -153.66% | -20.40% | 1.72% |
| Return on Tangible Assets | -135.59% | -20.08% | 9.42% |
| Earnings Yield | 0.00% | 0.00% | 0.00% |
| Efficiency Ratios | |||
| Receivables Turnover | 16.94 | 12.68 | 7.43 |
| Payables Turnover | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 1.05 | 0.10 |
| Fixed Asset Turnover | 4.76 | 125.63 | 1.19 |
| Asset Turnover | 0.78 | 0.57 | 0.21 |
| Working Capital Turnover Ratio | 0.65 | 0.74 | 0.00 |
| Cash Conversion Cycle | 21.55 | 375.66 | 3877.09 |
| Days of Sales Outstanding | 21.55 | 28.79 | 49.12 |
| Days of Inventory Outstanding | 0.00 | 346.87 | 3827.97 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 21.55 | 375.66 | 3877.09 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -5.97 | 35.15 | -13.41 |
| Capital Expenditure Coverage Ratio | -5.97 | 35.15 | -13.41 |
| Operating Cash Flow Coverage Ratio | -8.95 | 0.00 | -4.46 |
| Operating Cash Flow to Sales Ratio | -0.87 | 0.08 | -2.79 |
| Free Cash Flow Yield | 0.00% | 0.00% | 0.00% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | 0.00 | 0.00 | 0.00 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.00 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | 0.00 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | 0.28 | 3.20 | 2.04 |
| Enterprise Value | -1.05M | -3.68M | 273.21K |
| EV to EBITDA | 0.28 | 3.20 | 2.04 |
| EV to Sales | -0.48 | -1.09 | 0.31 |
| EV to Free Cash Flow | 0.47 | -13.52 | -0.10 |
| EV to Operating Cash Flow | 0.55 | -13.14 | -0.11 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.00 | -0.05 | 0.25 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.00 | 0.00 | 0.00 |
| Tax Burden | 1.00 | 1.05 | 0.75 |
| Interest Burden | 1.00 | 0.95 | 5.50 |
| Research & Development to Revenue | 0.94 | 0.60 | 0.00 |
| SG&A to Revenue | 1.16 | 0.33 | 0.73 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.50 | -0.24 | -6.15 |
Currency in USD

